Skip to main content

Table 7 Drug-likeness properties

From: Quantitative structure-activity relationship, molecular docking, drug-likeness, and pharmacokinetic studies of some non-small cell lung cancer therapeutic agents

Molecule

MW

No. of H-bond acceptors

No. of H-bond donors

TPSA

WLOGP

Lipinski’s RO5 violations

Molecule 4

614.16

7

3

137.17

5.2

1

Molecule 12

662.85

8

3

140.41

4.55

2

Molecule 16

546.42

6

3

94.65

4.76

1

Molecule 27

551.04

6

4

123.75

2.91

1

Molecule 29

579.05

6

4

140.82

2.83

2